The trademark FINILBRI was filed by Alexion Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on May 29, 2022, and received one opposition filed on July 4, 2022 by LABORATORIOS FARMACEUTICOS ROVI, S.A. on Likelihood of confusion. the opponent was represented by BALDER IP LAW, S.L. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued July 4, 2022
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on January 10, 2023.